VEGFR2 drugs for Hepatocellular Carcinoma
2 tracked VEGFR2 drugs in the Hepatocellular Carcinoma race. The class explanation lives on the VEGFR2 page; the full indication pipeline across every mechanism is on the Hepatocellular Carcinoma page.
1 approved / phase 41 Phase 3
Head-to-head evidence: Apatinib vs Ramucirumab